Reclassification of Software Automated Medical Devices

Description

Software-automated medical devices are transforming healthcare by leveraging advanced algorithms to perform critical tasks traditionally handled by medical professionals. From automated insulin delivery systems to AI-powered diagnostic tools and robotic surgical assistants, these innovations enhance accuracy, efficiency, and patient outcomes. However, their classification is a complex process dictated by regulatory bodies like the FDA, EMA, and other global authorities. These agencies assess devices based on patient risk levels, intended use, and potential impact on safety and efficacy—directly influencing approval, compliance requirements, and market access. As the medical device landscape evolves, understanding the nuances of classification is crucial for ensuring regulatory alignment and maintaining a competitive edge.

Why You Should Attend:

Navigating regulatory classifications for software-driven medical devices is more challenging than ever, with evolving global standards, reclassification hurdles, and the push for international harmonization. This webinar offers an in-depth look at the latest classification frameworks, their impact on compliance,…